DEF 14A
ALNYLAM PHARMACEUTICALS, INC.
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Filed
- April 28, 2005
- Period of Report
- June 8, 2005
- Accession Number
- 0000950135-05-002297
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →